Zobrazeno 1 - 7
of 7
pro vyhledávání: '"I. S. Bryukhovetskiy"'
Publikováno v:
Успехи молекулярной онкологии, Vol 6, Iss 1, Pp 63-72 (2019)
Background. Treatment of glioblastoma multiforme remains little effective due to the rapidly developing recurrence of the tumor, due to its high tumorigenic potential, resistance to chemoradiation therapy and increased dissemination of glioma stem ce
Externí odkaz:
https://doaj.org/article/acec70657b044d9a9b8f28cdb6ef069b
Autor:
V. E. Shevchenko, A. S. Bryukhovetskiy, M. V. Filatov, V. S. Burdakov, Z. N. Nikiforova, I. S. Bryukhovetskiy, Yu. D. Vasilets, T. I. Kushnir, N. E. Arnotskaya
Publikováno v:
Успехи молекулярной онкологии, Vol 5, Iss 1, Pp 60-69 (2018)
Background. Multiple myeloma (MM) is a hematologic malignancy of plasma cells. The microenvironment plays a key role in MM cell survival and drug resistance through release of soluble factors, expression of adhesion molecules and release of exosomes
Externí odkaz:
https://doaj.org/article/ab53387211b74acbb314daf245e97323
Autor:
V. E. Shevchenko, I. S. Bryukhovetskiy, Z. N. Nikiforova, S. V. Kovalev, I. A. Kudryavtsev, N. E. Arnotskaya
Publikováno v:
Успехи молекулярной онкологии, Vol 4, Iss 3, Pp 67-74 (2017)
Background. The transforming growth factor beta 1 (TGF-β1) is one of the most important tissue factors secreted by the development of epithelial tumors. Increased expression of TGF-β1 in lung tumors promotes cancer cells survival enhancing their gr
Externí odkaz:
https://doaj.org/article/6f3b40dc61e849f7bcb302a3e8ac2ee8
Autor:
V. E. Shevchenko, S. V. Kovalev, N. E. Arnotskaya, Z. N. Nikiforova, I. A. Kudryavtsev, E. A. Savchenko, I. S. Bryukhovetskiy
Publikováno v:
Успехи молекулярной онкологии, Vol 3, Iss 2, Pp 50-59 (2016)
Background. Increased expression of transforming growth factor beta-1 (TGF-β1) in malignant brain tumors promotes cancer cells survival enhancing their growth, migration, invasion, angiogenesis, immune system suppression.Objective is to study molecu
Externí odkaz:
https://doaj.org/article/a08540554faf42d081d5e4f04cf5c892
Autor:
Z. N. Nikiforova, I. A. Kudryavtsev, N. E. Arnotskaya, I. S. Bryukhovetskiy, V. E. Shevchenko
Publikováno v:
Успехи молекулярной онкологии, Vol 3, Iss 2, Pp 26-33 (2016)
Glioblastoma multiforme, a World Health Organization grade IV malignant glioma, is the most common and lethal primary brain tumor with the median survival of approximately 15–25 months after treatment. Glioblastoma multiforme has been shown to be r
Externí odkaz:
https://doaj.org/article/f0a3b2b07c7440ba8132662675ad82c5
Autor:
I S Bryukhovetskiy, A S Bryukhovetskiy
Publikováno v:
Journal of Clinical Practice. 5:44-60
In the article the authors present analysis of current conventional methodological and technological approaches to contemporary therapy of cancer and certain malignant neoplasms. Based upon the revision of available concepts of clinical oncology, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d9003670225a51040660dc0a29be26af
https://doi.org/10.17816/clinpract5144-60
https://doi.org/10.17816/clinpract5144-60
Publikováno v:
Journal of Clinical Practice. 4:45-54
Modern methods for the treatment of malignant brain tumors are insufficiently effective. One reason for this is that the existing technologies and methods are focused on removing all neoplastic cellsfrom the body. Understanding the mechanisms of syst
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1aa22b0bd3cd9f8366ac6c26f1fc682e
https://doi.org/10.17816/clinpract4445-54
https://doi.org/10.17816/clinpract4445-54